| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |